APA (7th ed.) Citation

Wang, K., Ding, J., Li, X., Guo, W., Zhu, X., Su, Y., . . . Ding, L. (2022). Effects of itraconazole and rifampicin on the pharmacokinetics and safety of youkenafil, a novel phosphodiesterase type 5 inhibitor, in healthy Chinese subjects. European journal of pharmaceutical sciences, 175, 106213. https://doi.org/10.1016/j.ejps.2022.106213

Chicago Style (17th ed.) Citation

Wang, Keli, Juefang Ding, Xianjing Li, Wenjing Guo, Xingyu Zhu, Yue Su, Luning Sun, Huan Zhou, and Li Ding. "Effects of Itraconazole and Rifampicin on the Pharmacokinetics and Safety of Youkenafil, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Chinese Subjects." European Journal of Pharmaceutical Sciences 175 (2022): 106213. https://doi.org/10.1016/j.ejps.2022.106213.

MLA (9th ed.) Citation

Wang, Keli, et al. "Effects of Itraconazole and Rifampicin on the Pharmacokinetics and Safety of Youkenafil, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Chinese Subjects." European Journal of Pharmaceutical Sciences, vol. 175, 2022, p. 106213, https://doi.org/10.1016/j.ejps.2022.106213.